HS
HighVista Strategies Portfolio holdings
AUM
$388M
1-Year Est. Return
180.25%
This Fund
S&P 500
1 Year Est. Return
+180.25%
AUM
$408M
AUM Growth
+$136M
(+50%)
Holding
175
Top Buys
| 1 | +$8.17M | |
| 2 | +$4.71M | |
| 3 | +$4.7M | |
| 4 |
CDTX
Cidara Therapeutics
CDTX
|
+$4.52M |
| 5 |
Arcellx
ACLX
|
+$4.35M |
Top Sells
| 1 | +$6.01M | |
| 2 | +$4.58M | |
| 3 | +$4M | |
| 4 |
AMED
Amedisys
AMED
|
+$3.86M |
| 5 |
Western Digital
WDC
|
+$2.97M |
Sector Composition
| 1 | Healthcare | 59% |
| 2 | Technology | 12.01% |
| 3 | Industrials | 6.97% |
| 4 | Financials | 4.64% |
| 5 | Consumer Discretionary | 3.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Invesco DB Commodity Index Tracking Fund
DBC
$1.47B
| $32.4M | 7.93% |
1,436,136
|
|
||
|
ABVX
2
Abivax
ABVX
$8.78B
| $15.7M | 3.84% |
184,468
+133,312
|
|
||
|
MRUS
3
DELISTED
Merus
MRUS
| $12.6M | 3.08% |
133,321
+43,559
|
|
||
4
Viridian Therapeutics
VRDN
$2.89B
| $10.1M | 2.48% |
469,335
-15,224
|
|
||
5
Revolution Medicines
RVMD
$19.6B
| $8.19M | 2.01% |
175,448
+107,400
|
|
||
6
Protagonist Therapeutics
PTGX
$6.01B
| $8.08M | 1.98% |
121,682
+63,831
|
|
||
7
Nuvalent
NUVL
$7.87B
| $8.07M | 1.98% |
93,294
+42,834
|
|
||
8
Mineralys Therapeutics
MLYS
$2.32B
| $7.96M | 1.95% |
209,829
+59,691
|
|
||
|
9
Arcellx
ACLX
$6.59B
| $7.9M | 1.94% |
96,177
+60,463
|
|
||
10
Agios Pharmaceuticals
AGIO
$1.71B
| $7.84M | 1.92% |
195,298
+125,171
|
|
||
11
Cytokinetics
CYTK
$7.51B
| $7.31M | 1.79% |
132,930
+64,278
|
|
||
12
Insmed
INSM
$31.5B
| $7.19M | 1.76% |
49,949
+38,354
|
|
||
|
CDTX
13
DELISTED
Cidara Therapeutics
CDTX
| $6.79M | 1.66% |
+70,904
|
|
||
14
Cogent Biosciences
COGT
$6.04B
| $6.64M | 1.63% |
462,405
+179,219
|
|
||
15
Structure Therapeutics
GPCR
$4.44B
| $6.61M | 1.62% |
236,236
+149,615
|
|
||
16
Amazon
AMZN
$2.24T
| $5.8M | 1.42% |
26,393
+7,500
|
|
||
|
SNDK
17
Sandisk
SNDK
$83.5B
| $5.32M | 1.31% |
47,451
+7,851
|
|
||
18
Enliven Therapeutics
ELVN
$1.75B
| $5.3M | 1.3% |
259,135
+117,619
|
|
||
|
AKRO
19
DELISTED
Akero Therapeutics
AKRO
| $5.23M | 1.28% |
110,079
+50,086
|
|
||
20
Praxis Precision Medicines
PRAX
$9.21B
| $5.04M | 1.23% |
95,002
+27,714
|
|
||
21
Microsoft
MSFT
$3T
| $4.9M | 1.2% |
9,458
-800
|
|
||
22
Olema Pharmaceuticals
OLMA
$1.93B
| $4.28M | 1.05% |
437,179
+158,749
|
|
||
23
BridgeBio Pharma
BBIO
$12.7B
| $4.26M | 1.04% |
81,959
+14,460
|
|
||
24
Apogee Therapeutics
APGE
$4.84B
| $4.26M | 1.04% |
107,107
+62,055
|
|
||
25
Immunovant
IMVT
$5.65B
| $4.08M | 1% |
253,127
+70,319
|
|